Raphael R. Steimbach
Impact in
-
- Sulfur Compounds in Biology
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Chemical Synthesis and Analysis
Papers in
-
- Histone Deacetylase Inhibitors Research 10
- Epigenetics and DNA Methylation 5
- Protein Degradation and Inhibitors 5
- Ubiquitin and proteasome pathways 2
- Oncology 5
- Peptidase Inhibition and Analysis 4
- Co-authors
- Aubry K. Miller (14 shared papers)Michael Morgen (3 shared papers)Nikolas Gunkel (4 shared papers)Ina Oehme (4 shared papers)Johannes Ridinger (4 shared papers)Corey J. Herbst‐Gervasoni (4 shared papers)David W. Christianson (4 shared papers)Peter Sehr (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (3 papers)ChemBioChem (2 papers)Nature Communications (1 paper)Journal of Medicinal Chemistry (1 paper)ChemMedChem (1 paper)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Raphael R. Steimbach
17 papers receiving 332 citations
Peers
Comparison fields: 5 of 59
- Biochemistry 40
- Molecular Biology 265
- Oncology 88
- Organic Chemistry 70
- Process Chemistry and Technology 7
Countries citing papers authored by Raphael R. Steimbach
This map shows the geographic impact of Raphael R. Steimbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael R. Steimbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael R. Steimbach more than expected).
Fields of papers citing papers by Raphael R. Steimbach
This network shows the impact of papers produced by Raphael R. Steimbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael R. Steimbach. The network helps show where Raphael R. Steimbach may publish in the future.
Co-authors
The 25 scholars most cited alongside Raphael R. Steimbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 68 | |
| 2 | 2019 | 39 | |
| 3 | 2022 | 31 | |
| 4 | 2020 | 28 | |
| 5 | 2020 | 23 | |
| 6 | 2023 | 21 | |
| 7 | 2022 | 21 | |
| 8 | 2022 | 18 | |
| 9 | 2023 | 16 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 15 | |
| 12 | 2020 | 12 | |
| 13 | 2024 | 7 | |
| 14 | 2024 | 7 | |
| 15 | 2019 | 6 | |
| 16 | 2025 | 4 | |
| 17 | 2021 | 4 |
About Raphael R. Steimbach
Raphael R. Steimbach is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Biochemistry and Pathology and Forensic Medicine, having authored 17 papers that have together received 336 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (10 papers), Epigenetics and DNA Methylation (5 papers), Protein Degradation and Inhibitors (5 papers), Peptidase Inhibition and Analysis (4 papers), Ubiquitin and proteasome pathways (2 papers), Adenosine and Purinergic Signaling (2 papers), Catalytic C–H Functionalization Methods (2 papers) and Sulfur Compounds in Biology (2 papers). The work is most often cited by research in Biochemistry (40 citations), Molecular Biology (265 citations), Oncology (88 citations), Organic Chemistry (70 citations) and Process Chemistry and Technology (7 citations). Raphael R. Steimbach has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Aubry K. Miller, Michael Morgen, Nikolas Gunkel, Ina Oehme, Johannes Ridinger, Corey J. Herbst‐Gervasoni, David W. Christianson, Peter Sehr, Tobias P. Dick and Uladzimir Barayeu. Their work appears in journals such as European Journal of Medicinal Chemistry, ChemBioChem, Nature Communications, Journal of Medicinal Chemistry and ChemMedChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.